A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension

Condition:   Autism Spectrum Disorder Interventions:   Drug: Balovaptan;   Drug: Placebo Sponsor:   Hoffmann-La Roche Not yet recruiting

Source: ClinicalTrials.gov - April 20, 2018 Category: Research Source Type: clinical trials